The results showed that the WNT5A gene was highly related to chemotherapeutic resistance because when WNT5A was knocked down by shRNA, the tumor became drug sensitive; overall, the findings suggest that pathogenesis of castration-resistant prostate cancer (CRPC) is strongly related to the non-classical WNT pathway [96]. This evidence concerns the gene WNT5A and neoplasm.